Bot Detector
LEARN MORE
A subscription to
IJPC
provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.
LEARN MORE
Sign On
The Journal
Editor-In-Chief
Editorial Calendar
Submissions
Advertising
Permissions & Reprints
Privacy Policy
Contact Us
Subscribe
Renew
Prices
Free Sample
View Cart
Articles
Issues
Archives
Supplemental Content and Errata
Training and Education
IJPC-PCAB SOP Matrix
USP GAP Analysis
Compounders' Network List
Patient Information
Videos
Compounders' Resource Directory
Sep/Oct 2021 - Volume 25, Number 5
Purchase the entire back issue in electronic PDF or print format.
(Select Format)
PDF — $95
Print Copy — $95
Purchase individual articles by selecting the article in the table below...
Individual Articles - Sep/Oct 2021 - Volume 25, Number 5
Title/Author
(Click for Abstract / Details / Purchase)
Issue/Page
View/Buy
PreScription: Permissible Exposure Limits and United States Pharmacopeia Chapter <800>
Allen Loyd V Jr
Sep/Oct 2021
Pg. 356
Determining Whether a Substance is Legal to Compound with Under Section 503A of the FDCA
Cabaleiro Joe
Sep/Oct 2021
Pg. 358-362
Filling the Gaps on the Institute for Safe Medication Practices (ISMP) Do Not Crush List for Immediate-release Products
Uttaro Elizabeth
,
Zhao Fang
,
Schweighardt Anne
Sep/Oct 2021
Pg. 364-371
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone
Riepl Mike
Sep/Oct 2021
Pg. 372-377
Realities of Pharmaceutical Compounding in the Republic of Uzbekistan
Umarov Ulugbek
,
Zdoryk Oleksandr
,
Kolisnyk Sergii
,
Fatkhullaeva Muyussar
Sep/Oct 2021
Pg. 378-384
It's Time for a New Philosophy
Brunner Scott
Sep/Oct 2021
Pg. 386-387
Quality Control: How to Produce a Well-closed Sealed Vial in a Regulated CGMP Environment: Part 2
Higgins Doral (Neal) O
,
Prudom Melanie J
,
Summers Amy
Sep/Oct 2021
Pg. 389-395
Basics of Compounding: Excipients Used in Nonsterile Compounding, Part 11: Drug Tastes: Innate, Induced, and Improved
Allen Loyd V Jr
Sep/Oct 2021
Pg. 396-400
Basics of Sterile Compounding: Intravenous Admixture Preparation, Part 11: Particulate Issues --- Silicone Oil in Vials, Cartridges, and Syringes
Allen Loyd V Jr
Sep/Oct 2021
Pg. 403-408
Calculations
Stockton Shelly J
Sep/Oct 2021
Pg. 410
Atropine Sulfate 0.1 mg/mL in SyrSpend SF pH4 Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 412
Cilazapril 1-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 413
Clonidine 0.01-mg/mL in Ora-Blend Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 414
Dapsone 2-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 415
Dexamethasone 1-mg/mL in Oral Mix or Oral Mix SF Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 416
Haloperidol 0.5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 417
Imipramine Hydrochloride 5-mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 418
Mycophenolate Mofetil 50-mg/mL in Ora-Plus:Cherry Syrup Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 419
Sorafenib 20-mg/mL in Oil Oral Suspension
Allen Loyd V Jr
Sep/Oct 2021
Pg. 420
Spironolactone 2-mg/mL or 2-5.mg/mL in SyrSpend SF pH4
Allen Loyd V Jr
Sep/Oct 2021
Pg. 421
Compatibility of Gestrinone, Nimesulide, and Piroxicam in Pentravan for Transdermal and Transmucosal Application
Polonini Hudson
,
de Oliveira Ferreira Anderson
,
Dijkers Eli
Sep/Oct 2021
Pg. 422-426
Stability of Diazepam Enema Extemporaneous Formulation in Manzoni Base
Lopalco Antonio
,
Lopedota Angela
,
Aurelio Fiorenza
,
la Forgia Flavia
,
Fontana Sergio
,
Franco Massimo
,
Denora Nunzio
Sep/Oct 2021
Pg. 427-430
Physicochemical and Microbiological Stability of Extemporaneously Compounded Hydrocortisone Oral Suspensions in PCCA Base, SuspendIt
Pramar Yashoda V
,
Mandal Tarun K
,
Bostanian Levon A
,
Kader Cyndy
,
Morris Tommy C
,
Graves Richard A
Sep/Oct 2021
Pg. 431-439
Return to Top